亚太宏总体基因体学市场：按类型、应用和国家 - 分析和预测（2024-2033）

2023年亚太地区总体基因体学市场规模为3.761亿美元。

预计2024年至2033年该市场将以19.65%的复合年增长率成长，2033年达到22.38亿美元。亚太地区的总体基因体学市场正在迅速扩大，因为它可以对实验室无法培养的微生物群落进行研究。透过使用基因组技术直接从环境样本中研究微生物基因组，总体基因体学正在彻底改变我们对微生物多样性和功能的认识。定序技术的改进、对微生物对健康影响的了解的增加以及总体基因体学在生物技术、农业和环境保护等行业的广泛使用是该市场成长的主要驱动力。

对新型酵素和抗生素的需求以及对个体化医疗日益增长的兴趣正在推动亚太地区的市场扩张。由于总体基因体学能够揭示有关微生物生态系统的重要讯息，因此它正在成为科学研究和商业应用的重要工具。

由于对先进基因组分析以了解微生物群落的需求不断增长，亚太地区的总体基因体学市场正在显着扩大。总体基因体学彻底改变了我们对微生物多样性和作用的理解，它使我们能够直接从环境样本中分析微生物基因组。在传统实验室培养技术不易取得的地区尤其如此。因此，亚太地区在医疗保健、农业、生物技术和环境管理等许多领域都取得了重大进展。

该市场主要由生物资讯工具和次世代定序（NGS）技术的开拓所驱动。人们越来越认识到微生物对人类健康、农业生产力和环境修復的影响，进一步促进了总体基因体学的研究和应用。此外，解决新兴市场的需求、客製化治疗的需求以及新抗生素的开发也推动了市场的成长。

该报告研究了亚太宏总体基因体学市场，并提供了市场概述，包括按类型、应用、国家和参与市场的公司概况分類的趋势。

目录

执行摘要

第一章 市场

• 生态系概述：总体基因体学市场
• 趋势：当前和未来的影响评估
• 研究发展回顾
• 监管状况
• 市场动态

第二章 区域

• 区域概况
• 促进因素和抑制因素
• 亚太地区

第三章市场－竞争基准化分析与公司概况

• 未来展望
• 生态系的主要参与企业
• 主要策略及发展
  • BGI Genomics
  • MGI Tech Co., Ltd.
  • Macrogen, Inc.
  • 总体基因体学市场的新兴企业

第四章调查方法

Introduction to Asia-Pacific (APAC) Metagenomics Market

The Asia-Pacific metagenomics market was valued at $376.1 million in 2023 and is expected to reach $2,238.0 million by 2033, growing at a CAGR of 19.65% between 2024 and 2033. The metagenomics market in Asia-Pacific (APAC) is expanding rapidly, driven by its ability to examine microbial communities that cannot be grown in laboratory. By studying microbial genomes directly from environmental samples using genomic analysis methods, metagenomics is revolutionizing our knowledge of microbial diversity and function. Improvements in sequencing technologies, growing knowledge of the health effects of microbes, and the widespread use of metagenomics in industries including biotechnology, agriculture, and environmental preservation are major drivers of this market's growth.

The demand for novel enzymes and antibiotics, as well as the growing interest in customized medicine, are driving the market's expansion in Asia Pacific. Metagenomics is becoming an essential tool for both scientific research and commercial applications because of its capacity to reveal important information about microbial ecosystems.

Market Introduction

The market for metagenomics in Asia-Pacific (APAC) is expanding significantly due to the growing need for sophisticated genomic analysis to comprehend microbial populations. Our understanding of microbial diversity and roles has been completely transformed by metagenomics, which makes it possible to analyze microbial genomes directly from environmental samples. This is particularly true in areas where conventional lab culture techniques are not readily available. As a result, APAC has seen notable advancements in a number of areas, including healthcare, agriculture, biotechnology, and environmental management.

This market is primarily driven by developments in bioinformatics tools and next-generation sequencing (NGS) technology. Metagenomics research and applications have been further stimulated by the increasing recognition of the effects of microbes on human health, agricultural productivity, and environmental restoration. The need to address developing diseases, the need for tailored therapy, and the development of new antibiotics have also spurred the market's growth.

Furthermore, the metagenomics market is expected to grow steadily as APAC economies make significant investments in scientific research and development. The technology is a vital tool for innovation in sectors that depend on an understanding of microbiomes for sustainable solutions because of its unrealized potential in analyzing complex microbial ecosystems.

Market Segmentation

Segmentation 1: by Product Type

• Consumables
• Instruments
• Services and Software

Segmentation 2: by Application

• Clinical Diagnostics
• Industrial Applications
• Research Applications

Segmentation 3: by Country

• Japan
• India
• China
• South Korea
• Australia
• Rest-of-Asia-Pacific

How can this report add value to an organization?

Product/Innovation Strategy: The APAC metagenomics market has been segmented based on various categories, such as product type, workflow, technology, application, and country.

Competitive Strategy: Key players are investing heavily in research and development to enhance their product portfolios and develop cutting-edge technologies for sample preparation, sequencing, and analysis. Strategic collaborations with academic institutions, research organizations, and industry partners are also key, facilitating access to diverse datasets and expertise. Furthermore, companies are focusing on expanding their market presence through geographic expansion and strategic acquisitions to capitalize on emerging opportunities and consolidate their market position.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analysing company coverage, product portfolio, and market penetration.

Some prominent names established in this market are:

• BGI Genomics
• MGI Tech Co., Ltd.
• Macrogen, Inc.

Table of Contents

Executive Summary

Scope and Definition

1 Markets

• 1.1 Ecosystem Overview: Metagenomics Market
• 1.2 Trends: Current and Future Impact Assessment
  • 1.2.1 Expansion into New Application Areas
  • 1.2.2 Increasing Collaborations and Partnerships among Key Players
• 1.3 Research and Development Review
  • 1.3.1 Patent Filing Trend (by Country, Company)
• 1.4 Regulatory Landscape
• 1.5 Market Dynamics
  • 1.5.1 Market Drivers
    • 1.5.1.1 Significant Reduction in Sequencing Costs Leading to an Increase in the Number of Metagenomics Studies
    • 1.5.1.2 High Incidence of Infectious Diseases
    • 1.5.1.3 Technological Advancements in Metagenomics
  • 1.5.2 Market Restraints
    • 1.5.2.1 Challenge of Securely Storing Vast Volumes of Sequenced Data
    • 1.5.2.2 Challenges Involved in Data Analysis of Metagenomics Sequencing and Lack of Clear Knowledge
  • 1.5.3 Market Opportunities
    • 1.5.3.1 Opportunity for Metagenomics in Microplastic Remediation
    • 1.5.3.2 Focus on Metagenomics Research on Antibiotic-Resistant Bacteria and Antibiotic-Resistant Genes

2 Regions

• 2.1 Regional Summary
• 2.2 Drivers and Restraints
• 2.3 Asia-Pacific
  • 2.3.1 Regional Overview
  • 2.3.2 Factors Driving the Market Growth
  • 2.3.3 Factors Impeding/Limiting the Market Growth
  • 2.3.4 By Type
  • 2.3.5 By Application
  • 2.3.6 China
    • 2.3.6.1 By Type
    • 2.3.6.2 By Application
  • 2.3.7 Japan
    • 2.3.7.1 By Type
    • 2.3.7.2 By Application
  • 2.3.8 India
    • 2.3.8.1 By Type
    • 2.3.8.2 By Application
  • 2.3.9 Australia
    • 2.3.9.1 By Type
    • 2.3.9.2 By Application
  • 2.3.10 South Korea
    • 2.3.10.1 By Type
    • 2.3.10.2 By Application
  • 2.3.11 Rest-of-Asia-Pacific
    • 2.3.11.1 By Type
    • 2.3.11.2 By Application

3 Markets - Competitive Benchmarking & Company Profiles

• 3.1 Next Frontiers
• 3.2 Active Key Players in The Ecosystem
• 3.3 Key Strategies and Developments
  • 3.3.1 BGI Genomics
    • 3.3.1.1 Overview
    • 3.3.1.2 Top Products
    • 3.3.1.3 Top Competitors
    • 3.3.1.4 Key Personnel
    • 3.3.1.5 Analyst View
  • 3.3.2 MGI Tech Co., Ltd.
    • 3.3.2.1 Overview
    • 3.3.2.2 Top Products/Product Portfolio
    • 3.3.2.3 Top Competitors
    • 3.3.2.4 Key Personnel
    • 3.3.2.5 Analyst View
  • 3.3.3 Macrogen, Inc.
    • 3.3.3.1 Overview
    • 3.3.3.2 Top Products/Product Portfolio
    • 3.3.3.3 Top Competitors
    • 3.3.3.4 Key Personnel
    • 3.3.3.5 Analyst View
  • 3.3.4 Emerging Companies in the Metagenomics Market

4 Research Methodology

• 4.1 Data Sources
  • 4.1.1 Primary Data Sources
  • 4.1.2 Secondary Data Sources
  • 4.1.3 Data Triangulation
• 4.2 Market Estimation and Forecast

List of Figures

• Figure 1: Asia-Pacific Metagenomics Market, $Million, 2024, 2028 and 2033
• Figure 2: Metagenomics Market (by Region), $Million, 2023, 2027, and 2033
• Figure 3: Asia-Pacific Metagenomics Market (by Application), $Million, 2023, 2027, and 2033
• Figure 4: Asia-Pacific Metagenomics Market (by Clinical Diagnostics), $Million, 2023, 2027, and 2033
• Figure 5: Asia-Pacific Metagenomics Market (by Product Type), $Million, 2023, 2027, and 2033
• Figure 6: Key Industrial Developments in Metagenomics Market, 2023-2024
• Figure 7: Ecosystem Overview and Operational Challenges
• Figure 8: Applications of Metagenomics in Different Research Areas
• Figure 9: Strategies Undertaken by Key Players, 2021-2024
• Figure 10: Strategic Collaborations and Partnerships, January 2021-April 2024
• Figure 11: Number of Metagenomics Patents (by Country), January 2020-April 2024
• Figure 12: Number of Metagenomics Patents (by Year), January 2020-December 2023
• Figure 13: Impact Analysis of Market Navigating Factors, 2023-2033
• Figure 14: Sequencing Cost over Time, 2007, 2014 and 2023
• Figure 15: Increase in Number of Metagenomics Publications, 2019-2023
• Figure 16: Estimated Number of Incident Tuberculosis Cases, Globally, Million, 2016 and 2021
• Figure 17: Incidence of Influenza A and B in India, Million, 2022-2033
• Figure 18: Increase in Metagenomics Research and Infectious Disease Publications, 2019-2023
• Figure 19: Advancements in the Metagenomics Market (by Technology)
• Figure 20: Challenges Related to Storing Sequenced Data
• Figure 21: Global Plastic Pollution, 1950-2050
• Figure 22: Forecasted Death Rates from Antimicrobial Resistance Vs. Current Leading Causes of Mortality
• Figure 23: China Metagenomics Market, $Million, 2023-2033
• Figure 24: Japan Metagenomics Market, $Million, 2023-2033
• Figure 25: India Metagenomics Market, $Million, 2023-2033
• Figure 26: Australia Metagenomics Market, $Million, 2023-2033
• Figure 27: South Korea Metagenomics Market, $Million, 2023-2033
• Figure 28: Rest-of-Asia-Pacific Metagenomics Market, $Million, 2023-2033
• Figure 29: Strategic Initiatives, 2021-2024
• Figure 30: Share of Strategic Initiatives, 2021-2024
• Figure 31: Strategic Initiatives (by Year), 2021-2024
• Figure 32: Data Triangulation
• Figure 33: Top-Down and Bottom-Up Approach
• Figure 34: Assumptions and Limitations

List of Tables

• Table 1: Market Snapshot
• Table 2: Metagenomics Market, Market Opportunities
• Table 3: Key Trends, Metagenomics Market
• Table 4: Examples of Metagenomics in New Applications
• Table 5: Regulatory Scenario of Metagenomics
• Table 6: Different Generations of NGS Platforms Showing Technological Advancements
• Table 7: Metagenomics Market (by Region), $Million, 2023-2033
• Table 8: Asia-Pacific Metagenomics Market (by Type), $Million, 2023-2033
• Table 9: Asia-Pacific Metagenomics Market (by Application), $Million, 2023-2033
• Table 10: China Metagenomics Market (by Type), $Million, 2023-2033
• Table 11: China Metagenomics Market (by Application), $Million, 2023-2033
• Table 12: Japan Metagenomics Market (by Type), $Million, 2023-2033
• Table 13: Japan Metagenomics Market (by Application), $Million, 2023-2033
• Table 14: India Metagenomics Market (by Type), $Million, 2023-2033
• Table 15: India Metagenomics Market (by Application), $Million, 2023-2033
• Table 16: Australia Metagenomics Market (by Type), $Million, 2023-2033
• Table 17: Australia Metagenomics Market (by Application), $Million, 2023-2033
• Table 18: South Korea Metagenomics Market (by Type), $Million, 2023-2033
• Table 19: South Korea Metagenomics Market (by Application), $Million, 2023-2033
• Table 20: Rest-of-Asia-Pacific Metagenomics Market (by Type), $Million, 2023-2033
• Table 21: Rest-of-Asia-Pacific Metagenomics Market (by Application), $Million, 2023-2033
• Table 22: Some of the Key Players in Metagenomics Market
• Table 23: Emerging Companies in Metagenomics Market